Home Covid-19 Updates Pfizer says COVID-19 vaccine 90% effective in Phase 3 trial

Pfizer says COVID-19 vaccine 90% effective in Phase 3 trial

Covid-19 vaccines

A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing COVID-19 infections in ongoing Phase 3 trials, the companies announced Monday. Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings.Covid-19 vaccine

The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” Pfizer Chairman and CEO Albert Bourla said in a statement.

“We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.

“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most,” Bourla added. Across much of the globe, COVID-19 infections rates are soaring to record highs, with hospital intensive care units filling up and death tolls mounting as well.

Based on supply projections, the companies said they expect to supply up to 50-million vaccine doses globally in 2020, and up to 1.3-billion doses in 2021.

In other news – Heartbreaking video of Moana screaming for help while trapped inside burning Car as people watch helplessly

Video vixen and fitness bunny Michelle Amuli, popularly known on social media as Mimi Moana who died Sunday early morning in a car accident along with businessman Genius Kadungure, who is well known on the social media streets as Ginimbi, and two of her friends. Learn more

Source: eNCA